Comparing two types of stents for heart artery treatment
Part of Heart & circulation clinical trials.
This trial compares a newer type of stent (with very thin struts and a coating that dissolves) to a standard stent in people having a heart artery procedure. It aims to see if the new stent works as well or better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You need one or more drug-coated stents to open a blocked heart artery.
- You are able to understand and agree to take part in the study.
- You are not in severe cardiogenic shock or on a breathing machine.
- You speak and understand Danish.
- You are not already taking part in the SORT OUT XII study.
- You are expected to live at least one year.
- You are not allergic to any of the study treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new type of stent (a small tube that props open a narrowed heart artery) coated with a medicine called everolimus to keep the artery open. The study wants to see if the stent is safe and works well for people with coronary artery disease, which is narrowing of the heart's blood vessels.
This trial compares two types of drug-coated stents (one with sirolimus, one with everolimus) in people who have had a heart attack or unstable angina and need a stent. It aims to see which stent works better for new blockages in the heart arteries.
This study looks at patients who received a special type of heart stent (a small mesh tube that holds open a blocked artery) during a procedure called angioplasty at Geneva University Hospitals. The goal is to see how safe and effective this stent is in everyday practice.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This trial compares two drug-coated stents for treating blocked heart arteries, with or without vitamin C (ascorbic acid). It tests whether sirolimus plus vitamin C is as safe and effective as everolimus. If you need a stent, this study may help determine which medication coating works best for you.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.